Metropolis Healthcare Ltd

Metropolis Healt | 542650

Market Closed

₹582.25

₹0.12 (-0.02%)

As on 02/09/26, 2:10 AM

Market Cap12,075.14 CR

Current Price₹582.25

High / Low₹609.05 / 412.25

PE Ratio47.3

Book Value₹72.46

Dividend Yield1.15%

ROCE17.24%

ROE11.96%

Face Value₹2.00

Current Vol.3,76,476

Average Vol.---

ISININE112L01020

PB Ratio5.99

Debt to Equity0.15

Net Profit Margin11.62

Operating Margin25.63

METROPOLIS - Share Price Chart

+₹0.00 (+0.00%)6M

Stock Performance

₹582.35₹582

₹582.25

Previous CloseToday's Open

₹412.25₹609.05

₹582.25

52W Low52W High

₹582Today's Open

₹582.35Previous Close

3,76,476Volume

₹412.2552W Low

₹609.0552W High

Ratios

No data available

About Company

Sushil Kanubhai Shah, one of the Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr
Desai's Hospital, having Dr
Sushil Kanubhai Shah and Dr
Vasant Kalyandas Desai as partners
The partnership was continued by Dr
Sushil Kanubhai Shah, Dr
Duru Sushil Shah from September 30, 1981 onwards
In June 1989, upon death of Dr
Shah, the partnership was continued by Dr
Sushil Kanubhai Shah and Dr

Ethics: Metropolis Healthcare Ltd is flagged for

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

Adequate

The company demonstrates adequate ESG practices with room for improvement.

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI57.76

SMA 20564.39

SMA 50563.59

SMA 100537.94

SMA 200505.46

SMA 10565.27

MACD_12_26_Days3.28

EMA10Day570.86

EMA20Day567.48

EMA50Day559.31

MACD_12_26_9_Days2.90

EMA100Day541.50

EMA200Day520.81

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth23.64%

ROE13.44%

EBITDA Margin25.63%

All figures in ₹ Crores

Indicators	2026	2025	2024	2023	2022
Revenue	1,645.85	1,331.20	1,207.71	1,148.21	1,228.34
Interest	24.54	18.57	22.54	26.80	19.74
Expenses	1,245.00	1,028.21	925.13	859.91	885.54
Financing Profit	426.43	318.11	291.69	303.52	360.41
Financing Margin %	26%	24%	24%	26%	29%
Other Income	25.58	15.11	9.12	15.22	17.62
Depreciation	133.72	108.68	94.47	89.22	63.22
Profit before tax	259.18	190.85	174.69	187.50	293.35
Tax %	26%	24%	26%	24%	27%
Net Profit	191.18	145.51	128.46	143.39	214.69
EPS in Rs	9.19	7.07	24.95	27.91	41.87

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
ADITYA BIRLA SUN LIFE MUTUAL FUND	11 Aug ‘26	Purchase	10,49,000	₹564	519.55%
ICICI PRUDENTIAL MUTUAL FUND	11 Aug ‘26	Purchase	5,25,500	₹564	260.27%
MORGAN STANLEY ASIA SINGAPORE PTE	11 Aug ‘26	Purchase	5,25,500	₹564	260.27%
DURU SHAH FAMILY TRUST	11 Aug ‘26	Sell	10,50,000	₹564	520.05%
METZ ADVISORY LLP	11 Aug ‘26	Sell	10,50,000	₹564	520.05%
GOLDMAN SACHS BANK EUROPESE - ODI	16 Oct ‘25	Purchase	55,000	₹1,944	123.19%
GOLDMAN SACHS (SINGAPORE) PTE.- ODI	16 Oct ‘25	Sell	55,000	₹1,944	123.19%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	03 Oct ‘22	Sell	64,642	₹1,554.35	29.27%
ISHARES CORE MSCI EMERGING MARKETS ETF	03 Oct ‘22	Purchase	64,642	₹1,554.35	29.27%
ISHARES INDIA SC MAURITIUS COMPANY	03 Oct ‘22	Sell	8,568	₹1,554.35	3.88%

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

18 Aug 2026

AGM

24 Jul 2026

19 May 2026

Interim 2 Dividend (₹1)

Declared 2nd Interim Dividend of INR 1/- (Indian Rupee One only) per equity share of face value of INR 2/- (Indian Rupees Two only) each for the financial year 2025-26. The record date for the purpose of payment of Interim Dividend shall be Tuesday, May 19, 2026. The Interim Dividend will be paid within 30 days of its declaration.

13 May 2026

20 Mar 2026

Bonus Issue (3:1)

3:1 Bonus Issue of Equity Shares

11 Mar 2026

11 Nov 2025

Interim 1 Dividend (₹4)

Declared Interim Dividend of INR 4/- (Indian Rupees Four only) per equity share of face value of INR 2/- (Indian Rupees Two only) each for the financial year 2025-26.

04 Nov 2025

13 Aug 2025

AGM

22 Jul 2025

21 Aug 2024

AGM

31 Jul 2024

17 Nov 2023

Interim Dividend (₹4)

This is to inform you that, the Board of Directors in their meeting held today i.e 4th November, 2023, has approved the declaration of an Interim Dividend of Rs. 4 per share and has fixed Friday, 17th November, 2023 as the record date.

04 Nov 2023

17 Aug 2023

AGM

21 Jul 2023

23 Feb 2023

Interim Dividend (₹8)

This is to inform you that the Board of Directors of the Company at their Meeting held today i.e. Friday, February 10, 2023 have inter-alia: ii. Approved and Declared payment of an Interim Dividend at the rate of Rs. 8/- (Rupees Eight Only) per Equity Share on the Face Value of Rs. 2/- (Rupees Two Only) per Equity Share for the Financial Year 2022-23. The Board has fixed Thursday, February 23, 2023, as the 'Record Date'. The Interim Dividend will be paid to the shareholders within 30 days of declaration.

10 Feb 2023

17 Aug 2022

AGM

20 Jul 2022

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
583	12,086	58	8	35	0	11.62%
8,763	1,25,998	60	13	42	1	7.94%
747	98,259	105	6	59	1	8.87%
1,007	98,009	65	9	50	0	17.23%
911	68,769	64	7	45	0	11.20%
758	66,090	170	14	100	0	7.26%
1,938	39,605	46	9	29	1	10.21%
1,457	39,163	68	10	48	0	12.56%
1,904	31,950	57	13	44	0	18.45%
759	31,878	153	9	59	2	6.20%

Showing 10 of 70 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in just 5 minutes*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

EPLEPL Ltd
₹240.35-21.71 (-8.28%)

Group Stocks

Adani Stocks

Tata Group Stocks

Frequently Asked Questions

What is Share Price of Metropolis Healthcare Ltd?

The current share price of Metropolis Healthcare Ltd (Metropolis Healt) is ₹582.25. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Metropolis Healthcare Ltd?

The Price-to-Earnings (P/E) ratio of Metropolis Healthcare Ltd is 582.25. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Metropolis Healthcare Ltd?

Metropolis Healthcare Ltd has a 52-week high of ₹609.05 and a 52-week low of ₹412.25. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Metropolis Healthcare Ltd?

Metropolis Healthcare Ltd offers a dividend yield of 0.86%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Metropolis Healthcare Ltd?

The Earnings Per Share (EPS) of Metropolis Healthcare Ltd is ₹10.04. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Metropolis Healthcare Ltd?

Metropolis Healthcare Ltd has a Return on Equity (ROE) of 11.96%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video